Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photobiomodulation on NMES-Induced Muscle Fatigue and Damage: A Pilot Study

NCT: NCT07790016 · COMPLETED

NCT IDNCT07790016
StatusCOMPLETED
Start Date2022-11-01
Completion2023-12-01
SponsorFederal University of Rio Grande do Sul (OTHER)
First posted
Last updated

Brief Summary

Neuromuscular electrical stimulation (NMES) is an effective tool for muscle strengthening and rehabilitation, but its clinical application is often limited by rapid neuromuscular fatigue, muscle discomfort, and potential muscle damage. Photobiomodulation therapy (PBMT) using low-level lasers or LEDs has been proposed as an ergogenic and protective modality capable of attenuating exercise-induced muscle fatigue and damage. However, evidence regarding the acute preventive effects of PBMT on NMES-induced fatigue and muscle damage in humans remains limited and conflicting. The purpose of this randomized, sham-controlled, crossover pilot trial was to evaluate the acute effects of PBMT applied prior to an NMES-induced fatigue protocol on knee extensor neuromuscular fatigability, muscle damage, discomfort, and functional performance in healthy young individuals. Healthy participants had both lower limbs randomized to receive either active PBMT (810 nm, 240 J total per limb across 8 points) or sham PBMT 5 minutes prior to an NMES fatigue protocol (20 minutes of evoked isometric contractions at 20% of maximal voluntary contraction). Primary and secondary outcomes-including maximal voluntary isometric contraction (MVIC) torque, supramaximal twitch torque, muscle damage via ultrasound echointensity (rectus femoris and vastus lateralis), pain pressure thresholds (algometry), visual analog scale (VAS) for discomfort, and functional tests (Single Hop Test and stair ascent/descent)-were assessed at baseline, immediately post-fatigue, and at 24, 48, and 72 hours post-intervention.

Frequently Asked Questions

What is Photobiomodulation on NMES-Induced Muscle Fatigue and Damage: A Pilot Study?

Photobiomodulation on NMES-Induced Muscle Fatigue and Damage: A Pilot Study is a clinical trial registered under NCT07790016. Current status: COMPLETED.

What is the status of NCT07790016?

The current status of NCT07790016 (Photobiomodulation on NMES-Induced Muscle Fatigue and Damage: A Pilot Study) is: COMPLETED.

When did Photobiomodulation on NMES-Induced Muscle Fatigue and Damage: A Pilot Study start?

Photobiomodulation on NMES-Induced Muscle Fatigue and Damage: A Pilot Study started on 2022-11-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.